Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading update

15 Jan 2021 07:00

RNS Number : 7819L
Babcock International Group PLC
15 January 2021
 

15 January 2021 

Babcock International Group PLC (Babcock or the Group)

Trading update

 

Babcock, the aerospace and defence company, issues the following trading update for the first nine months of the financial year ending 31 March 2021.

 

Group trading

Trading in the third quarter saw a continuation of trends in the first half of the year, with weakness in our civil aviation businesses and a negative impact from COVID-19.

 

Underlying revenue in the nine months year to date (YTD) was £3,399 million (9M 2020: £3,574 million), down 3% on last year excluding disposals and FX. Underlying operating profit in the nine months YTD was £202 million (9M 2020: £320 million), down 34% excluding disposals and FX, with a negative impact from civil nuclear insourcing, COVID-19 and civil aviation.

 

Order intake YTD was £3.1 billion with the Group's order book standing at £16.8 billion at 31 December 2020 (31 March 2020: £17.6 billion).

 

Balance sheet

The Group's net debt1 (excluding lease obligations) at 31 December 2020 was £1,207 million, a reduction of £255 million compared to 31 December 20192. Although this position is higher than that reported at 30 September 2020 of £871 million, it is consistent with the average net debt for the first nine months of this financial year of £1,222 million3.

 

Review of contract profitability and balance sheet

We have recently started a detailed review of our balance sheet and contract profitability. Early indications suggest that there may be negative impacts on the balance sheet and/or income statement for current and/or future years. This review is being supported by an independent accounting firm and the outputs will be reviewed by our auditor (PWC), Audit Committee and Board prior to the publication of our audited results for the year ending 31 March 2021 expected in May.

 

Outlook

Uncertainty remains around the outturn for this financial year, especially given that our fourth quarter is historically our strongest and that the COVID-19 situation has worsened in most of our markets. Given this uncertainty, and the start of our review of contract profitability and balance sheet, we continue not to provide financial guidance for this financial year.

 

Review of strategic priorities

We announced a review of the Group's strategic priorities in November 2020 and this is now well underway. Our focus throughout this review will be on cash delivery, being a strategic partner to the UK Government, international growth, driving innovation across the Group, and transforming our ESG and people agenda. We will outline our refreshed strategy alongside our full year results.

 

David Lockwood, CEO said:

"While trading in the third quarter has continued to reflect the challenges of the first half and there remain a number of near term uncertainties, the fundamental strengths of the Group and the opportunities ahead give us confidence for future years and I look forward to reporting back at the full year results".

 

 

For further information please contact:

 

Babcock International Group PLC

Simon McGough Kate Hill

Director of Investor Relations Group Director of Communications

Tel: +44 (0)7850 978 741 Tel: +44 (0)20 7355 5312

 

FTI Consulting

John Waples / Nick Hasell / Alex Le May

Tel: +44 (0)20 3727 1340

 

 

Notes

1. Net debt includes the benefit of ongoing receivables factoring and supply chain finance programmes.

2. This includes net proceeds from the sales of Context, Holdfast and Conbras of £194 million.

3. Based on the average of nine month end positions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFSEELEFSEFF
Date   Source Headline
12th Nov 20187:00 amRNSResponse to speculation and update on trading
9th Oct 20189:00 amRNSSite Visit
19th Sep 20187:00 amRNSTrading Update
7th Sep 201810:35 amRNSPublication of a Prospectus
14th Aug 20183:04 pmRNSDirector/PDMR Shareholding
3rd Aug 20189:47 amRNSDirector/PDMR Shareholding
30th Jul 20187:00 amRNSStatement re: article in The Sunday Times
24th Jul 201810:35 amRNSDirector/PDMR Shareholding
20th Jul 201810:41 amRNSDirector/PDMR Shareholding
20th Jul 201810:40 amRNSDirector/PDMR Shareholding
20th Jul 201810:37 amRNSDirector/PDMR Shareholding
19th Jul 20181:00 pmRNSResult of AGM
19th Jul 20187:00 amRNSAnnual General Meeting Trading Update
29th Jun 201810:14 amRNSHolding(s) in Company
15th Jun 20189:37 amRNSHolding(s) in Company
14th Jun 20185:48 pmRNSDirector/PDMR Shareholding
14th Jun 20184:30 pmRNSNotice of AGM
14th Jun 201810:42 amRNSDirector/PDMR Shareholding
31st May 201810:00 amRNSContract Extension
23rd May 20187:00 amRNSFinal Results
10th May 20189:47 amRNSHolding(s) in Company
24th Apr 20189:56 amRNSHolding(s) in Company
27th Mar 201811:26 amRNSDirector/PDMR Shareholding
23rd Mar 20188:37 amRNSDirector Declaration
14th Mar 20184:18 pmRNSHolding(s) in Company
12th Mar 20188:53 amRNSDirector/PDMR Shareholding
9th Mar 20188:56 amRNSDirector/PDMR Shareholding
16th Feb 201812:46 pmRNSHolding(s) in Company
15th Feb 201812:34 pmRNSHolding(s) in Company
15th Feb 201812:32 pmRNSHolding(s) in Company
6th Feb 20187:00 amRNSTrading Update
19th Jan 20184:57 pmRNSHolding(s) in Company
19th Jan 20182:08 pmRNSHolding(s) in Company
18th Jan 20189:00 amRNSBabcock awarded Italian firefighting contract
17th Jan 20184:56 pmRNSDirector/PDMR Shareholding
12th Jan 20189:39 amRNSHolding(s) in Company
10th Jan 201810:19 amRNSHolding(s) in Company
8th Jan 20187:00 amRNSBabcock launches 'Team 31' bid for new UK frigate
3rd Jan 20187:00 amRNSBabcock signs agreement with Australian Navy
21st Dec 20177:00 amRNSDirectorate Change
18th Dec 20177:00 amRNSContract Award
11th Dec 20177:00 amRNSStatement re: Adoption of IFRS 15
6th Dec 201712:50 pmRNSDirector/PDMR Shareholding
30th Nov 20174:23 pmRNSDirector Declaration
29th Nov 201711:18 amRNSDirector/PDMR Shareholding
27th Nov 20172:10 pmRNSDirector/PDMR Shareholding
27th Nov 20172:05 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSHalf-year Report
16th Nov 20172:00 pmRNSContract Award
16th Oct 20178:28 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.